With CytRx Corporation (NYSE:CYTR) shares on the move and Synergy Pharmaceuticals Inc (NASDAQ:SGYP) raring up for a strategically executed launch for its CIC drug …
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, unveiled its proprietary LADR™ (Linker Activated Drug Release) technology platform, a …
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announced the appointment of Cheryl Cohen, former Chief Commercial Officer of …
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announced positive updated results from its ongoing Phase 2 clinical trial …
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announced that a case study, titled “Albumin-Linked Doxorubicin (Aldoxorubicin) as Treatment …
CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical research and development company specializing in oncology, announced the appointment of Anita J. Chawla, PhD, to its Board of …
CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced encouraging overall survival (OS) results, the secondary endpoint, from …
CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that the United States Food and Drug Administration (FDA) …
In a research report released August 8, H.C.
